Free Trial
NASDAQ:NRXS

NeurAxis 11/12/2024 Earnings Report

NeurAxis logo
$2.17 -0.15 (-6.34%)
As of 12:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NeurAxis EPS Results

Actual EPS
-$0.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeurAxis Revenue Results

Actual Revenue
$0.67 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeurAxis Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

NeurAxis' next earnings date is estimated for Monday, May 19, 2025, based on past reporting schedules.

Conference Call Resources

NeurAxis Earnings Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More NeurAxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeurAxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeurAxis and other key companies, straight to your email.

About NeurAxis

NeurAxis (NASDAQ:NRXS), a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

View NeurAxis Profile

More Earnings Resources from MarketBeat